38例原发性肝癌介入治疗临床观察  

Clinical Observation of Primary Liver Cancer Interventional Therapy with 38 Cases

作　　者：王浩 

机构地区：[1]垫江县中医院,重庆408300

出　　处：《亚太传统医药》2013年第6期138-139,共2页Asia-Pacific Traditional Medicine

摘　　要：目的:探讨原发性肝癌介入治疗的临床疗效。方法:对照组36例给予经肝动脉栓塞化疗(TA-CE)治疗,实验组38例给予经肝动脉栓塞化疗(TACE)+超声引导微波凝固(PMCT)介入治疗,对比分析两组患者的临床疗效。结果:对照组、实验组总有效率分别为66.67%、92.11%,实验组总有效率明显高于对照组,两组差异有统计学意义(P<0.05)。结论:对原发性肝癌患者给予TACE+PMCT介入治疗,可提高临床疗效,促进疾病治疗。Objective：To investigate the clinical efficacy of the interventional treatment of primary liver cancer. Methods：36 cases in the control group treated by transcatheter arterial chemoembolization （TACE） treatment, 38 cases in experimental group were given to transcatheter arterial chemoembolization （TACE）＋ ultrasound guided microwave coagulation （PMCT） intervention, com- parative analysis of the clinical efficacy of the two groups. Results：In the control group and experimental group, the total effective rate were 66.67%, 92.11 %, the total efficiency was higher than that in the control group, the experimental group, there was significant difference between two groups （P〈0.05）. Conclusion： TACE-＋-PMCT interventional therapy on patients with primary liver cancer, and can improve the clinical curative effect, promote disease treatment.

关 键 词：原发性肝癌 TACE PMCT 介入治疗 

分 类 号：R735.7[医药卫生—肿瘤]